UViiVE

Autonomous science from bits to bioactives

Explore the Platform
Scroll

Why Now

Three things converged in 2026.

🤖

AI Agents That Do Science

Not just assistance — specialized agent fleets, shared memory, 24/7 autonomous execution. With trust.

⚙️

Physical Robots Closing the Loop

Molecular design to Kd measurement, functional experiments, and beyond. No human required.

🧬

De Novo Peptide Design

This unlocks topical bioactives at scale, and MoCRA is the regulatory arbitrage for rapid commercialization.

We build AI-designed precision peptides that target the root cause of skin conditions, not just the symptoms.

Market Opportunity

Redness is a large market.
Differentiation is not.

  • The market: ~$9B+ global redness-addressing skincare with ~5\u20138% CAGR, spanning face, lips, and body.
  • The demand today: Four dominant need states lead spend: UV-triggered, reactive/sensitive, barrier impairment, and post-procedure.
  • The competitive set:Shelves are crowded with look-alike naturals, broad “calms / soothes / reduces redness” claims, and limited true performance separation.
Our founders published the science. We're bringing it to the world.
UV-Triggered Sensitivity
Reactive Inflammation
Barrier Impairment
Post-Procedure Recovery
Competitive Skincare Landscape

Technology

The AI-Native Full Stack

Three specialized agents. Shared memory. 24/7 autonomous execution.

Uvy
Scientist & Strategist

Designs experiments, mines literature, manages the pipeline, coordinates the fleet. The brain that never sleeps.

Atlas
Compute Powerhouse

Runs local models, heavy inference, structural biology. The muscle behind the design loop.

Buster
GPU Workhorse

Protein folding, binder design, overnight batch jobs. Turns candidate lists into ranked hits.

Autonomous robotics
The atomic layer

Liquid handling. Cell free synthesis. Functional assays. While we sleep.

The Exponential Unlock

A Full Stack Agentic Fleet

The AI fleet designs. Robots execute: from in silico candidate to atomic experiment.

A design-test-rank loop that runs 24/7, gets smarter with every cycle.

Team

Meet the Team

Deep expertise in AI, protein engineering, and clinical dermatology — united to revolutionize precision biology.

SE
Stephen C. Ekker, PhD
Co-Founder
  • ·Discovered VEGF-A inhibition stops UV-induced erythema
  • ·Serial entrepreneur
  • ·Professor and Dean, UT Austin
MP
Milit Patel
Co-Founder
  • ·AI/ML scientist
  • ·Biotech, stats & data science
  • ·Protein engineer
WW
Wesley A. Wierson, PhD
Scientific Founder
  • ·Serial entrepreneur
  • ·Y Combinator backed founder
  • ·Translational protein engineering
  • ·Gene editing & cell therapies
SH
Stella Hartono, MD/PhD
Scientific Founder
  • ·Discovered VEGF-A inhibition stops UV-induced erythema
  • ·Clinical assistant professor, Stanford
  • ·Immunologist & allergist
VB
Victoria Bedelle, MD/PhD
Scientific Founder
  • ·Discovered VEGF-A inhibition stops UV-induced erythema
  • ·Anesthesiology & critical care

Vision

Closed loop. Autonomous.

Design→
Build→
Test
BioactivesDiagnosticsResearch Reagents

Get in Touch

Interested in learning more? Drop us a message.